Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
HealthStream
HSTM
HealthStream
Rising Costs And Regulations Will Dampen Healthcare Demand Amid Resilience
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
22 Jun 25
Updated
20 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$28.00
0.9% undervalued
intrinsic discount
20 Aug
US$27.74
Loading
1Y
-3.9%
7D
4.0%
Author's Valuation
US$28.0
0.9% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$28.0
0.9% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
332m
2014
2017
2020
2023
2025
2026
2028
Revenue US$331.9m
Earnings US$21.8m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
4.21%
Healthtech revenue growth rate
4.07%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.85%
Calculation
US$21.82m
Earnings '28
x
43.46x
PE Ratio '28
=
US$948.25m
Market Cap '28
US$948.25m
Market Cap '28
/
27.44m
No. shares '28
=
US$34.56
Share Price '28
US$34.56
Share Price '28
Discounted to 2025 @ 7.85% p.a.
=
US$27.55
Fair Value '25
